Description
ProteoGenix delivers end-to-end antibody engineering: humanization, bispecific formats, affinity maturation, ADC conjugation, labeling, and developability assessment—for therapeutic, diagnostic, and research use. With over 20+ years’ expertise, we offer “go-no-go” guarantees to minimize risk and ensure only viable candidates move forward. You retain full IP rights for engineered antibodies.